Paper34739733
Beta-blockers in patients without heart failure after myocardial infarction.
Safi S and 6 others. Cochrane Database Syst Rev, 2021. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Beta-blockers in patients without heart failure after myocardial infarction. Papers, record 34739733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34739733
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Myocardial Infarction | Major topic |
| Cause of Death | |
| Humans | |
| Middle Aged | |
| Quality of Life | |
| Stroke Volume | |
| Ventricular Function, Left |
Source PubMed
References163
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,731,452 | Effect of timolol on cardiopulmonary exercise performance in men after myocardial infarction. | Am J Cardiol | 1992 | https://conductscience.org/library/papers/1731452 | PubMed |
| 2 | 3,087,488 | Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity. | Br Med J (Clin Res Ed) | 1986 | https://conductscience.org/library/papers/3087488 | PubMed |
| 3 | 3,802,833 | Meta-analysis in clinical trials. | Control Clin Trials | 1986 | https://conductscience.org/library/papers/3802833 | PubMed |
| 4 | 1,098,398 | Deaths and non-fatal reinfarctions during two years' follow-up. | Acta Med Scand Suppl | 1975 | https://conductscience.org/library/papers/1098398 | PubMed |
| 5 | 6,207,983 | Results of long-term propranolol treatment in myocardial infarction survivors with advanced grades of ventricular extrasystoles. | Cor Vasa | 1984 | https://conductscience.org/library/papers/6207983 | PubMed |
| 6 | 12,111,919 | Quantifying heterogeneity in a meta-analysis. | Stat Med | 2002 | https://conductscience.org/library/papers/12111919 | PubMed |
| 7 | 32,206,809 | Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically. | Eur Heart J | 2020 | https://conductscience.org/library/papers/32206809 | PubMed |
| 8 | 6,752,712 | A long-term prevention study with oxprenolol in coronary heart disease. | N Engl J Med | 1982 | https://conductscience.org/library/papers/6752712 | PubMed |
| 9 | 7,038,157 | A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. | JAMA | 1982 | https://conductscience.org/library/papers/7038157 | PubMed |
| 10 | 22,279,115 | 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. | BMJ | 2012 | https://conductscience.org/library/papers/22279115 | PubMed |
| 11 | 28,886,621 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). | Eur Heart J | 2018 | https://conductscience.org/library/papers/28886621 | PubMed |
| 12 | 22,052,934 | AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | Circulation | 2011 | https://conductscience.org/library/papers/22052934 | PubMed |
| 13 | 28,847,619 | Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice. | Prog Cardiovasc Dis | 2017 | https://conductscience.org/library/papers/28847619 | PubMed |
| 14 | 23,771,844 | 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Eur Heart J | 2013 | https://conductscience.org/library/papers/23771844 | PubMed |
| 15 | 6,799,077 | One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6799077 | PubMed |
| 16 | 2,648,779 | Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. | Am Heart J | 1989 | https://conductscience.org/library/papers/2648779 | PubMed |
| 17 | 18,332,291 | A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. | Arch Intern Med | 2008 | https://conductscience.org/library/papers/18332291 | PubMed |
| 18 | 1,234,497 | An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. | Br J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1234497 | PubMed |
| 19 | 17,592,831 | Arcsine test for publication bias in meta-analyses with binary outcomes. | Stat Med | 2008 | https://conductscience.org/library/papers/17592831 | PubMed |
| 20 | 3,616,287 | Methods for combining randomized clinical trials: strengths and limitations. | Stat Med | 1987 | https://conductscience.org/library/papers/3616287 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,984,882 | Beta-blockers after acute coronary syndrome: insights across the ejection fraction spectrum. | Eur Heart J Open | 2026 | https://conductscience.org/library/papers/42984882 | PubMed |
| 42,473,525 | Treatment Effect of Beta-Blocker Therapy After Acute Myocardial Infarction With Preserved or Mildly Reduced Ejection Fraction: A Systematic Review and Trial Sequential Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42473525 | PubMed |
| 42,311,050 | Baseline Ejection Fraction as a Modifier of Beta-Blocker Therapeutic Effects in Post-Acute Coronary Syndrome Patients With Non-Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42311050 | PubMed |
| 42,256,677 | Beta-blocker therapy after myocardial infarction: an umbrella review. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/42256677 | PubMed |
| 41,817,868 | Harms of Continued Antihypertensives: An Overview of Reviews. | Drugs Aging | 2026 | https://conductscience.org/library/papers/41817868 | PubMed |
| 41,676,263 | Impact of sacubitril/valsartan on cardiac structure and function in post-acute myocardial infarction heart failure patients aged over 65: a single-center experience. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/41676263 | PubMed |
| 41,463,309 | Chronic β-Blockade and Systemic Homeostasis: Molecular Integration of Cardiorenal and Immune Pathways, a Narrative Review. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463309 | PubMed |
| 41,041,110 | Effectiveness of Beta-Blockers in Reducing Mortality and Recurrence After Myocardial Infarction: A Systematic Review of Contemporary and Foundational Evidence. | Cureus | 2025 | https://conductscience.org/library/papers/41041110 | PubMed |
| 40,385,272 | Beta-blockers in post-myocardial infarction with preserved ejection fraction: systematic review and meta-analysis. | Cardiovasc Diagn Ther | 2025 | https://conductscience.org/library/papers/40385272 | PubMed |
| 39,652,380 | Evaluation of RMES, an Automated Software Tool Utilizing AI, for Literature Screening with Reference to Published Systematic Reviews as Case-Studies: Development and Usability Study. | JMIR Form Res | 2024 | https://conductscience.org/library/papers/39652380 | PubMed |
| 39,301,488 | Machine learning models for predicting risks of MACEs for myocardial infarction patients with different VEGFR2 genotypes. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39301488 | PubMed |
| 36,635,926 | Role of β-blockers in Preventing Heart Failure and Major Adverse Cardiac Events Post Myocardial Infarction. | Curr Cardiol Rev | 2023 | https://conductscience.org/library/papers/36635926 | PubMed |
| 36,513,329 | Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). | Eur Heart J Cardiovasc Pharmacother | 2023 | https://conductscience.org/library/papers/36513329 | PubMed |
| 35,990,402 | Management of Heart Failure in Patients with Chronic Kidney Disease. | Eur Cardiol | 2022 | https://conductscience.org/library/papers/35990402 | PubMed |
| 32,852,697 | Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver? | Diabetes Ther | 2020 | https://conductscience.org/library/papers/32852697 | PubMed |
| 32,710,261 | Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials. | Diabetes Ther | 2020 | https://conductscience.org/library/papers/32710261 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34739733
GET https://conductscience.org/api/papers/v1/34739733/references?page=2